4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Familial Partial Lipodystrophy: new trials by email Literature Review of Familial Partial Lipodystrophy trials Research Report on Familial Partial Lipodystrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL) AKCEA-ANGPTL3-LRx - Familial Partial Lipodystrophy | Phase 2 | Completed | Akcea Therapeutics | 4 | 2018-06-15 | 2021-02-16 |
| Study of Gemcabene in Adults With FPLD 300mg Gemcabene, 600mg Gemcabene - Familial Partial Lipodystrophy, Hypertriglyceridemia | Phase 1 / Phase 2 | Completed | Elif Oral | 5 | 2018-03-13 | 2020-08-17 |
| Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients Obeticholic Acid, Placebo - Familial Partial Lipodystrophy | Phase 2 | Completed | Abhimanyu Garg | 10 | 2016-06-01 | 2024-08-27 |
| CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy Metreleptin - Familial Partial Lipodystrophy, Nonalcoholic Steatohepatitis | Phase 2 | Completed | University of Michigan | 11 | 2015-09-29 | 2020-11-24 |
Lipodystrophy, Familial Partial (4) · Fatty Liver (2) · Non-alcoholic Fatty Liver Disease (2) · Diabetes Mellitus, Lipoatrophic (1) · Dyslipidemias (1) · Hypertriglyceridemia (1) · Lipid Metabolism Disorders (1) · Lipodystrophy (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Laminopathies (4) · Lipid Metabolism, Inborn Errors (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Skin Diseases (4) · Skin Diseases, Metabolic (4) · Skin and Connective Tissue Diseases (4) · Digestive System Diseases (3) · Lipid Metabolism Disorders (3) · Lipodystrophy (3) · Liver Diseases (3) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1)
Investigational New Drug Application (1) · gemcabene (1) · metreleptin (1) · obeticholic acid (1)
Abhimanyu Garg (1) · Akcea Therapeutics (1) · Elif Oral (1) · University of Michigan (1)
United States (4)
Abhimanyu Garg, MD (1) · Elif A Oral, M.D. (1) · Elif A Oral, MD (1)